The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Mislocalization of protein kinase A drives pathology in Cushing’s syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“L205R uncouples binding of both RI and RII subunits as well as PKI by disrupting binding to the P+1 pocket (Walker et al., 2019), while W196R disrupts binding to the cyclic nucleotidebinding domain (CNB-A) of both RI and RII subunits (Omar et al., 2022;Gibson and Taylor, 1997).”
From Protein Kinase Structure and Dynamics: Role of the αC-β4 Loop (2023) · cites this paper as Omar et al., 2022
In the citing paper
“These hypotheses are now supported by extensive cellular studies carried out by Scott and coworkers [106], showing that L205R and W196R (two mutations linked to Cushing’s syndrome) elude spatiotemporal regulation, resulting in the activation of distinct, pathogenic signaling pathways.”
From An NMR portrait of functional and dysfunctional allosteric cooperativity in cAMP‐dependent protein kinase A (2023) · cites this paper as [106]
In the citing paper
“Also, phosphoproteomic studies revealed significant changes in the phosphorylation profile of this oncogenic kinase, suggesting a reduction in the enzyme’s substrate fidelity [104, 105] and/or mislocalization [106].”
From An NMR portrait of functional and dysfunctional allosteric cooperativity in cAMP‐dependent protein kinase A (2023) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073
Self-citationActivating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome
Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232
Sanderson, J. L., Gorski, J. A., & Dell’Acqua, M. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.043 · Cited by 210
Di Dalmazi, G., Kisker, C., Calebiro, D., Mannelli, M., Canu, L., Arnaldi, G., Quinkler, M., Rayes, N., Tabarin, A., Laure Jullié, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2152 · Cited by 119
Current knowledge on the acute regulation of steroidogenesis
Selvaraj, V., Stocco, D. M., & Clark, B. J. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy102 · Cited by 118
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation
Ronchi, C. L., Di Dalmazi, G., Faillot, S., Sbiera, S., Assié, G., Weigand, I., Calebiro, D., Schwarzmayr, T., Appenzeller, S., Rubin, B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1586 · Cited by 93
Walker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9298 · Cited by 71
Research works printed but not linked: 57
- Amunjela, 2019, The role of the Popeye domain containing gene family in organ homeostasis, Cell, 8
- Baffi, 2021, mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif, Sci. Signal., 14, eabe4509, 10.1126/scisignal.abe4509 · DOI
- Bathon, 2019, Alterations in protein kinase A substrate specificity as a potential cause of cushing syndrome, Endocrinology, 160, 447, 10.1210/en.2018-00775 · DOI · Paper page
- Bauman, 2006, Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes, Molecular cell, 23, 925, 10.1016/j.molcel.2006.07.025 · DOI · Paper page
- Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome, N. Engl. J. Med., 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
- Bock, 2021, Optical mapping of cAMP signaling at the nanometer scale, Cell, 184, 2793, 10.1016/j.cell.2021.04.043 · doi:10.1016/j.cell.2021.04.043
- Branon, 2018, Efficient proximity labeling in living cells and organisms with TurboID, Nat. Biotechnol., 36, 880, 10.1038/nbt.4201 · DOI · Paper page
- Byrne, 2016, cAMP-dependent protein kinase (PKA) complexes probed by complementary differential scanning fluorimetry and ion mobility-mass spectrometry, Biochem. J., 473, 3159, 10.1042/BCJ20160648 · DOI
- Daly, 2021, Oxygen-dependent changes in binding partners and post-translational modifications regulate the abundance and activity of HIF-1α/2α, Science signaling, 14, eabf6685, 10.1126/scisignal.abf6685 · DOI
- Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 · DOI · Paper page
- Di Dalmazi, 2020, RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights, J. Clin. Endocrinol. Metab., 105, e4459, 10.1210/clinem/dgaa616 · DOI
- Dostmann, 1990, Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3’, 5’-cyclic phosphorothioates, J. Biol. Chem., 265, 10484, 10.1016/S0021-9258(18)86973-3 · DOI · Paper page
- Dumontet, 2018, PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal, JCI Insight, 3, e98394, 10.1172/jci.insight.98394 · DOI
- Espiard, 2018, Activating PRKACB somatic mutation in cortisol-producing adenomas, JCI Insight, 3, 98296, 10.1172/jci.insight.98296 · DOI
- Ferries, 2017, Evaluation of parameters for confident phosphorylation site localization using an Orbitrap fusion Tribrid mass spectrometer, J. Proteome Res., 16, 3448, 10.1021/acs.jproteome.7b00337 · DOI
- Freedman, 2013, Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells, Dev. Cell., 26, 666, 10.1016/j.devcel.2013.07.016 · DOI · Paper page
- Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat. Genet., 46, 613, 10.1038/ng.2956 · DOI · Paper page
- Hernández-Ramírez, 2018, Genetics of Cushing's syndrome, Endocrinol. Metab. Clin. N. Am., 47, 275, 10.1016/j.ecl.2018.02.007 · DOI
- Holderfield, 2014, Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond, Nat. Rev. Cancer., 14, 455, 10.1038/nrc3760 · DOI · Paper page
- Horn, 2014, KinomeXplorer: an integrated platform for kinome biology studies, Nat. Methods, 11, 603, 10.1038/nmeth.2968 · DOI · Paper page
- Isensee, 2018, PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity termination, J. Cell. Biol., 217, 2167, 10.1083/jcb.201708053 · DOI
- Kwan, 2016, DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2, Genesis, 30, 2696
- Lacroix, 2015, Cushing's syndrome, Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 · DOI · Paper page
- Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nat. Rev. Mol. Cell. Biol., 16, 232, 10.1038/nrm3966 · DOI · Paper page
- Liu, 2017, Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector, Sci. Rep., 7, 2193, 10.1038/s41598-017-02460-2 · DOI · Paper page
- Lubner, 2017, Cushing's syndrome mutant PKA L 205R exhibits altered substrate specificity, FEBS. Lett., 591, 459, 10.1002/1873-3468.12562 · DOI · Paper page
- Ma, 2019, Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: a case report, Medicine, 98, e14866, 10.1097/MD.0000000000014866 · DOI
- Musheshe, 2018, cAMP: from long-range second messenger to nanodomain signalling, Trends. Pharmacol. Sci., 39, 209, 10.1016/j.tips.2017.11.006 · DOI · Paper page
- Newton, 2003, Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm, Biochem. J., 370, 361, 10.1042/bj20021626 · DOI · Paper page
- Niswender, 2005, Cre recombinase-dependent expression of a constitutively active mutant allele of the catalytic subunit of protein kinase A, Genesis, 43, 109, 10.1002/gene.20159 · DOI
- Omar, 2020, AKAP signaling islands: venues for precision pharmacology, Trends. Pharmacol. Sci., 41, 933, 10.1016/j.tips.2020.09.007 · DOI
- Palencia-Campos, 2020, Germline and mosaic variants in PRKACA and PRKACB cause a multiple congenital malformation syndrome, Am. J. Hum. Genet., 107, 977, 10.1016/j.ajhg.2020.09.005 · DOI · Paper page
- Pereira, 2019, MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors, J. Cell. Biochem., 120, 894, 10.1002/jcb.27451 · DOI
- Poppe, 2008, Cyclic nucleotide analogs as probes of signaling pathways, Nat. Methods, 5, 277, 10.1038/nmeth0408-277 · DOI · Paper page
- Ragazzon, 2006, Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis, Endocrinology, 147, 1805, 10.1210/en.2005-1279 · DOI · Paper page
- Rinaldi, 2019, Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system, Nat. Commun., 10, 2572, 10.1038/s41467-019-10037-y · DOI
- Rosenberg, 2002, Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues, Ann. N. Y. Acad. Sci., 968, 65, 10.1111/j.1749-6632.2002.tb04327.x · DOI · Paper page
- Sandberg, 1991, Characterization of Sp-5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3’, 5’-monophosphorothioate (Sp-5, 6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells, Biochem. J., 279, 521, 10.1042/bj2790521 · DOI
- Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
- Scott, 2009, Cell signaling in space and time: where proteins come together and when they're apart, Science, 326, 1220, 10.1126/science.1175668 · DOI · Paper page
- Shabb, 2001, Physiological substrates of cAMP-dependent protein kinase, Chem. Rev., 101, 2381, 10.1021/cr000236l · DOI · Paper page
- Smith, 2017, Local protein kinase A action proceeds through intact holoenzymes, Science, 356, 1288, 10.1126/science.aaj1669 · DOI · Paper page
- Smith, 2010, AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade, Nat. Cell. Biol., 12, 1242, 10.1038/ncb2130 · DOI
- Smith, 2018, Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins, Proc. Natl. Acad. Sci. U S A, 115, E11465, 10.1073/pnas.1816614115 · DOI
- Smith, 2013, Intrinsic disorder within an AKAP-protein kinase A complex guides local substrate phosphorylation, Elife, 2, e01319, 10.7554/eLife.01319 · DOI
- Stratakis, 2018, Cyclic AMP-dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next, J. Pathol., 244, 257, 10.1002/path.5014 · DOI · Paper page
- Szklarczyk, 2019, STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic. Acids. Res., 47, 10.1093/nar/gky1131 · DOI · Paper page
- Taskén, 2004, Localized effects of cAMP mediated by distinct routes of protein kinase A, Physiol. Rev., 84, 137, 10.1152/physrev.00021.2003 · DOI · Paper page
- Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell. Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
- Turnham, 2016, Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology, Genewatch, 577, 101
- Turnham, 2019, An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma, Elife, 8, e44187, 10.7554/eLife.44187 · DOI
- Van, 2021, Protein kinase C fusion proteins are paradoxically loss of function in cancer, J. Biol. Chem., 296, 100445, 10.1016/j.jbc.2021.100445 · DOI
- Viña, 2021, cAMP compartmentalization in cerebrovascular endothelial cells: new therapeutic opportunities in alzheimer's disease, Cells, 10, 10.3390/cells10081951 · DOI
- Yarwood, 2020, Special issue on "new advances in cyclic AMP signalling"-an editorial overview, Cells, 9, 10.3390/cells9102274 · DOI
- Yu, 2013, The Hippo pathway: regulators and regulations, Genes & development, 27, 355, 10.1101/gad.210773.112 · DOI · Paper page
- Yu, 2019, ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling, Aging, 11, 12295, 10.18632/aging.102572 · DOI
- Zhang, 2012, Structure and allostery of the PKA RIIβ tetrameric holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
Cited by
Olivieri, C., Wang, Y., Walker, C., Subrahmanian, M. V., Ha, K. N., Bernlohr, D., Gao, J., Camilloni, C., Vendruscolo, M., Taylor, S. S., et al. (2024) · eLife · doi:10.7554/elife.91506.3 · Cited by 18
Protein Kinase Structure and Dynamics: Role of the αC-β4 Loop
Wu, J., Jonniya, N. A., Hirakis, S. P., Olivieri, C., Veglia, G., Kornev, A. P., & Taylor, S. S. (2023) · doi:10.1101/2023.08.31.555822 · Cited by 17
Olivieri, C., Walker, C., Veliparambil Subrahmanian, M., Porcelli, F., Taylor, S. S., Bernlohr, D. A., & Veglia, G. (2023) · FEBS Letters · doi:10.1002/1873-3468.14610 · Cited by 10
Metadata
- Authors
- Omar, M. H., Byrne, D. P., Jones, K. N., Lakey, T. M., Collins, K. B., Lee, K.-S., Daly, L. A., Forbush, K. A., Lau, H.-T., Golkowski, M., McKnight, G. S., Breault, D. T., Lefrançois-Martinez, A.-M., Martinez, A., Eyers, C. E., Baird, G. S., Ong, S.-E., Smith, F. D., Eyers, P. A., & Scott, J. D.
- ORCID
- Omar, Mitchell H.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 40
- Issue
- 2
- Pages
- 111073
- ISSN
- 2211-1247
- Cited by
- 38
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institutes of Health (F32DK121415, R01DK119192, R01DK119186, R01GM129090)
- Biotechnology and Biological Sciences Research Council (BB/S018514/1, BB/T018127/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.